EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 255 filers reported holding EDITAS MEDICINE INC in Q2 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $63,648,258 | +1.8% | 8,160,033 | +7.4% | 0.00% | 0.0% |
Q2 2023 | $62,512,576 | +16.2% | 7,595,696 | +2.4% | 0.00% | 0.0% |
Q1 2023 | $53,783,126 | -17.4% | 7,418,362 | +1.1% | 0.00% | 0.0% |
Q4 2022 | $65,094,641 | -23.8% | 7,338,742 | +5.1% | 0.00% | -33.3% |
Q3 2022 | $85,469,000 | +7.4% | 6,982,775 | +3.8% | 0.00% | 0.0% |
Q2 2022 | $79,547,000 | -33.4% | 6,724,210 | +7.2% | 0.00% | 0.0% |
Q1 2022 | $119,355,000 | -17.3% | 6,275,270 | +15.5% | 0.00% | -25.0% |
Q4 2021 | $144,256,000 | -35.5% | 5,433,376 | -0.2% | 0.00% | -33.3% |
Q3 2021 | $223,638,000 | -29.3% | 5,444,010 | -2.5% | 0.01% | -33.3% |
Q2 2021 | $316,346,000 | +31.3% | 5,585,189 | -2.7% | 0.01% | +28.6% |
Q1 2021 | $240,971,000 | -35.2% | 5,737,376 | +8.1% | 0.01% | -41.7% |
Q4 2020 | $371,962,000 | +141.1% | 5,305,406 | -3.5% | 0.01% | +100.0% |
Q3 2020 | $154,282,000 | +4.6% | 5,498,275 | +10.2% | 0.01% | 0.0% |
Q2 2020 | $147,536,000 | +77.5% | 4,987,680 | +19.0% | 0.01% | +50.0% |
Q1 2020 | $83,128,000 | -33.8% | 4,192,049 | -1.2% | 0.00% | -20.0% |
Q4 2019 | $125,582,000 | +33.9% | 4,241,198 | +2.8% | 0.01% | +25.0% |
Q3 2019 | $93,792,000 | -2.1% | 4,124,456 | +6.5% | 0.00% | 0.0% |
Q2 2019 | $95,805,000 | +3.4% | 3,872,531 | +2.2% | 0.00% | 0.0% |
Q1 2019 | $92,625,000 | +10.6% | 3,788,345 | +2.9% | 0.00% | 0.0% |
Q4 2018 | $83,755,000 | -26.7% | 3,681,534 | +2.6% | 0.00% | -20.0% |
Q3 2018 | $114,207,000 | -7.7% | 3,589,141 | +3.9% | 0.01% | -16.7% |
Q2 2018 | $123,796,000 | +30.4% | 3,455,066 | +20.7% | 0.01% | +20.0% |
Q1 2018 | $94,930,000 | +15.6% | 2,863,624 | +7.1% | 0.01% | +25.0% |
Q4 2017 | $82,129,000 | +29.6% | 2,672,556 | +1.3% | 0.00% | +33.3% |
Q3 2017 | $63,361,000 | +49.1% | 2,638,892 | +4.2% | 0.00% | +50.0% |
Q2 2017 | $42,488,000 | +70.2% | 2,531,998 | +126.4% | 0.00% | +100.0% |
Q1 2017 | $24,966,000 | +624050.0% | 1,118,488 | +430087.7% | 0.00% | – |
Q4 2016 | $4,000 | 0.0% | 260 | 0.0% | 0.00% | – |
Q3 2016 | $4,000 | -33.3% | 260 | 0.0% | 0.00% | – |
Q2 2016 | $6,000 | -33.3% | 260 | 0.0% | 0.00% | – |
Q1 2016 | $9,000 | – | 260 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NIA IMPACT ADVISORS, LLC | 54,615 | $4,897,000 | 2.55% |
Capital Impact Advisors, LLC | 130,000 | $9,114,000 | 2.24% |
ARK Investment Management | 10,125,564 | $709,903,000 | 1.89% |
Nikko Asset Management Americas, Inc. | 4,388,143 | $307,653,000 | 1.75% |
Spectrum Planning & Advisory Services Inc. | 17,522 | $1,228,000 | 1.32% |
DDD Partners, LLC | 79,527 | $5,576,000 | 1.10% |
Brevan Howard Capital Management LP | 76,420 | $5,358,000 | 1.08% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 538,721 | $37,770,000 | 0.75% |
DC Investments Management, LLC | 3,627 | $254,000 | 0.63% |
Haafor (Singapore) Pte. Ltd. | 4,761 | $334,000 | 0.62% |